278 related articles for article (PubMed ID: 15273105)
1. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.
Jayaram R; Shandil RK; Gaonkar S; Kaur P; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Kantharaj E; Balasubramanian V
Antimicrob Agents Chemother; 2004 Aug; 48(8):2951-7. PubMed ID: 15273105
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
Shandil RK; Jayaram R; Kaur P; Gaonkar S; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Balasubramanian V
Antimicrob Agents Chemother; 2007 Feb; 51(2):576-82. PubMed ID: 17145798
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Jia L; Tomaszewski JE; Hanrahan C; Coward L; Noker P; Gorman G; Nikonenko B; Protopopova M
Br J Pharmacol; 2005 Jan; 144(1):80-7. PubMed ID: 15644871
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins.
Mitchison DA
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1186-9. PubMed ID: 22794180
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an intracellular pharmacokinetic in vitro infection model as a tool to assess tuberculosis therapy.
Cappelletty DM
Int J Antimicrob Agents; 2007 Feb; 29(2):212-6. PubMed ID: 17204402
[TBL] [Abstract][Full Text] [Related]
9. In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.
Jeena PM; Bishai WR; Pasipanodya JG; Gumbo T
Antimicrob Agents Chemother; 2011 Feb; 55(2):539-45. PubMed ID: 21098246
[TBL] [Abstract][Full Text] [Related]
10. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
11. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
12. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.
Jayaram R; Gaonkar S; Kaur P; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharat S; Shandil RK; Kantharaj E; Balasubramanian V
Antimicrob Agents Chemother; 2003 Jul; 47(7):2118-24. PubMed ID: 12821456
[TBL] [Abstract][Full Text] [Related]
14. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
[TBL] [Abstract][Full Text] [Related]
15. Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models.
Chen C; Wicha SG; de Knegt GJ; Ortega F; Alameda L; Sousa V; de Steenwinkel JEM; Simonsson USH
CPT Pharmacometrics Syst Pharmacol; 2017 Nov; 6(11):787-797. PubMed ID: 28657202
[TBL] [Abstract][Full Text] [Related]
16. Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.
Paramasivan CN; Kubendiran G; Herbert D
Indian J Med Res; 1998 Oct; 108():115-9. PubMed ID: 9805839
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacodynamics and pharmacokinetics of domestic fixed-dose combination of antituberculosis drugs].
Zhao W; Li H; Duan L; Liang G; Zhang T; Lu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):333-6. PubMed ID: 12126555
[TBL] [Abstract][Full Text] [Related]
18. Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.
Srivastava S; Musuka S; Sherman C; Meek C; Leff R; Gumbo T
J Infect Dis; 2010 Apr; 201(8):1225-31. PubMed ID: 20210628
[TBL] [Abstract][Full Text] [Related]
19. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
Shkurupií VA; Kurunov IN; Arkhipov SA
Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
